Boston Trust Walden’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$617K Hold
1,583
﹤0.01% 324
2026
Q1
$749K Hold
1,583
0.01% 307
2025
Q4
$739K Sell
1,583
-100
-6% -$46.4K 0.01% 300
2025
Q3
$717K Hold
1,683
0.01% 303
2025
Q2
$645K Hold
1,683
﹤0.01% 309
2025
Q1
$582K Sell
1,683
-85
-5% -$27.3K ﹤0.01% 308
2024
Q4
$531K Hold
1,768
﹤0.01% 313
2024
Q3
$719K Hold
1,768
0.01% 302
2024
Q2
$568K Hold
1,768
﹤0.01% 314
2024
Q1
$590K Hold
1,768
﹤0.01% 312
2023
Q4
$479K Hold
1,768
﹤0.01% 313
2023
Q3
$435K Hold
1,768
﹤0.01% 315
2023
Q2
$537K Hold
1,768
﹤0.01% 308
2023
Q1
$466K Buy
+1,768
New +$449K ﹤0.01% 317

Other funds holding HCA

Boston Trust Walden's HCA Position: Q2 2026 in Review

Boston Trust Walden held its HCA Healthcare (HCA) position steady in Q2 2026 at 1,583 shares worth $617K. The position accounts for ﹤0.01% of the portfolio, ranked #324.

Boston Trust Walden first reported a position in HCA in Q1 2023 and has held it in 14 quarters since. The position peaked at $749K in Q1 2026. 487 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Boston Trust Walden held 1,583 shares of HCA Healthcare worth $617K as of Q2 2026.
  • Boston Trust Walden left its HCA Healthcare share count unchanged in Q2 2026.
  • HCA Healthcare made up ﹤0.01% of Boston Trust Walden's portfolio in Q2 2026, its #324 holding.
  • Boston Trust Walden first reported a position in HCA Healthcare in Q1 2023 and has held it in 14 quarters since.
  • Boston Trust Walden's HCA Healthcare position peaked at $749K in Q1 2026.
  • 487 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.